Diffusion tensor imaging of occult injury of optic radiation following optic neuritis in multiple sclerosis

Jiafeng Chen1, Lijun Zhu2, He Li1

  • 1Department of Neurology, Neuroscience Centre, The First Teaching Hospital of Jilin University, Changchun, Jilin 130012, P.R. China.

Insights

Diffusion tensor imaging (DTI) detects subtle optic nerve and radiation damage in multiple sclerosis (MS) not visible with standard MRI. DTI shows early injury, aiding MS diagnosis and management.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Multiple sclerosis (MS) diagnosis relies on MRI, but routine scans miss early or occult lesions.
  • This discrepancy between MRI findings and clinical disability in MS patients is common.
  • Standard MRI may not fully capture the extent of optic nerve and radiation involvement.

Purpose of the Study:

  • To evaluate the sensitivity of diffusion tensor imaging (DTI) and diffusion tensor tractography (DTT) in detecting early optic nerve and radiation damage in MS.
  • To compare DTI/DTT metrics between MS patients and healthy controls.
  • To explore the utility of DTI in assessing occult injuries in MS.

Main Methods:

  • 10 relapsing-remitting MS patients and 10 controls underwent routine 3.0 T MRI, DTI, and DTT.
  • Optic nerves and optic radiations were analyzed using DTI and DTT.
  • Fractional anisotropy (FA) and mean diffusivity (MD), including λ// and λ┴, were measured.

Main Results:

  • DTI/DTT revealed abnormalities in both affected and unaffected optic nerves/radiations in MS patients.
  • Significantly lower FA and higher MD, λ//, and λ┴ values were observed in MS patients compared to controls (P<0.05).
  • No significant differences were found between affected and unaffected nerves/radiations within MS patients.

Conclusions:

  • Diffusion tensor imaging (DTI) is sensitive for detecting occult optic nerve and radiation injury in MS.
  • DTI may serve as a valuable tool for early diagnosis and management of MS.
  • DTI offers insights into the subclinical neurodegenerative processes in MS.